Update to BOPA Standards – New Guidance on Pharmacy Technician SACT Verification (Section 3.3)

Dear BOPA Members,

We are pleased to share an important update to the BOPA Standards for the Pharmacy Verification of Prescriptions for Cancer Medicines (Version 5.0, 3 June 2025).

A new section, 3.3 – Pharmacy Technician Verification Guidance to Organisations, has been added to support the development and safe implementation of pharmacy technician involvement in systemic anti-cancer therapy (SACT) verification at Level 2a.

Key highlights of this new guidance include:

  • Organisations are encouraged to consider their local governance frameworks when defining the responsibilities of pharmacy technicians in SACT verification (see also Section 3.1).
  • Minimum recommended criteria for technicians undertaking Level 2a verification:
    • Band 5 or 6 (or equivalent)
    • At least two years of cancer-specific experience
    • ACT (Accuracy Checking Technician) qualification
    • Ongoing post-qualification training (e.g. Level 4 Enhanced Practice Programme or Diploma in Clinical Pharmacy Services and Therapeutics)
  • A phased and competency-based approach to scope:
    • Technicians may be approved to verify either individual SACT items (e.g. zoledronic acid) or named items within specific disease areas (e.g. breast cancer: zoledronic acid, pamidronate, denosumab, trastuzumab SC only)
    • Scope may be expanded based on additional training, log completion, and local governance approval

This addition aims to enhance clarity and consistency across the UK, while supporting the safe development of pharmacy technician roles in cancer services.

With thanks to the task group who reviewed and contributed to this update, including:

  • Netty Cracknell – Principal Pharmacist – Operations, GenesisCare UK
  • Mollie Pelingu – Pharmacy Technician, The Royal Marsden NHS Foundation Trust
  • Joseph Williams – Pharmacist, The Christie NHS Foundation Trust
  • Emma Williams – Pharmacy Technician, Velindre University NHS Trust
  • Claire Kennedy – Pharmacy Technician, Oxford University Hospitals NHS Foundation Trust
  • Melanie Lowe – Chief Clinical Pharmacy Technician, The Christie NHS Foundation Trust

The updated Standard is available via this link: https://www.bopa.org.uk/resources/bopa-standards-for-clinical-pharmacy-verification-of-cancer-medicine-prescriptions/

We encourage all members to review the updated standards document and consider how these changes may be applied within your organisation.

Best regards,

BOPA

Latest News

By BOPA on behalf of ISOPP on 29th July 2025

ISOPP July 2025 Newsletter

Volume 27 | No.7 | July 2025 From Netty Cracknell, ISOPP President Dear BOPA members, This month has been incredibly busy, and while there are moments I feel completely exhausted,…

Read article
By BOPA on 23rd July 2025

Third Annual Cancer Associated Thrombosis Summit: North of England

The NEONC CAT conference returns this year on the 8th of November, in Hull. As the UK’s only dedicated cancer associated thrombosis (CAT) conference, it presents a unique opportunity for…

Read article
By BOPA on 22nd July 2025

BOPA Questionnaire – Monitoring and Treatments for Immune-Related Myocarditis

The BOPA Immunotherapy Specialist Interest Group invites all BOPA members to complete this survey. This builds on our previous work exploring the known disparity across the UK with regards to…

Read article
By BOPA on 22nd July 2025

BOPA Member on the current state and future trajectory of pharmacy in cancer services

As president of the International Society of Oncology Pharmacy Practitioners and co-chair of the UK SACT Board, BOPA Member Netty Cracknell is championing the role of oncology pharmacy in delivering…

Read article